Invest Now
Products Pricing Partners Refer & Earn

Platforms

Trading Options

Platforms

Trading Options

Pricing

Trading & Investing

Calculators

Support

Learn

IPO

About Us

Partners

Refer & Earn

Open an account Login

Bharat Parenterals Ltd Share Price

₹ 0.00 0 (0%)

Updated on 01-01-1970 5:30 AM

Stock Rating

Pros 2

 

Cons 5

Bharat Parenterals Ltd Price Performance

  • Day's Low
  • ₹0
  • Day's High
  • ₹0
₹ 0
  • 52-w low
  • ₹0
  • 52-w high
  • ₹0
0
  • Day's open
    ₹0
  • Previous close
    ₹0
  • VWAP
    ₹0
  • Lower price band
    ₹0
  • Upper price band
    ₹0

Today's Market Action

Its last traded stock price on BSE was 979.75 up by 5.00%. The total volume of shares on NSE and BSE combined was 482 shares. Its total combined turnover was Rs 0.05 crores.

Bharat Parenterals Ltd Medium and Long Term Market Action

The stock price of Bharat Parenterals Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.

Bharat Parenterals Ltd Fundamentals

  • Market Cap (Cr): 979

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Bharat Parenterals Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Bharat Parenterals Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Bharat Parenterals Ltd

Data not available.

Bharat Parenterals Ltd FAQ's

What is Share Price of Bharat Parenterals Ltd?

What is the Market Cap of Bharat Parenterals Ltd?

What is PE Ratio of Bharat Parenterals Ltd?

What is PB Ratio of Bharat Parenterals Ltd?

What is the CAGR of Bharat Parenterals Ltd?

How to Buy Bharat Parenterals Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • Above Average Sustainable RoE
    The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
  • Asset Light Business
    The company operates a great asset light business with a high Asset turnover ratio of 5.56. A high asset turnover ratio is a great driver of RoE and can improve shareholder returns. A relatively higher asset turnover ratio also will result in lower dilution as the business grows its revenues as earnings.

Cons

  • Poor Cash Flow Conversion
    The business has very poor cash conversion ratio of only -56.10% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
  • Low Interest Coverage
    The company has a very low Interest coverage ratio of 7.25 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 411 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • Poor Corporate Governance
    The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(10/03/2025)
Stock Valuation
Green line
96
100.00%
100.00% People are bullish about Bharat Parenterals Ltd
0.00%
0.00 % People are bearish about Bharat Parenterals Ltd

What is your opinion about this Stock?

Historical Data

Bharat Parenterals Ltd

₹ 0 (%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      ×

      Filing Complaints on SCORES

      Easy & quick Easy & quick

      1. Register on SCORES portal

      2. Mandatory details for filling complaints on SCORES

      Name | PAN | Address | Mobile | Number | E-mail ID

      3. Benefits

      Effective Communication

      Speedy redressal of the grievances

      Website Icon
      Open Free Account Now

      Open Free Trading & Demat Account

      +91